Sanofi and GlaxoSmithKline collaborate to speed up coronavirus vaccine development
IMAGINECHINA VIA AP
Sanofi plans to use technology from GlaxoSmithKline to accelerate the development of its experimental vaccine against the novel coronavirus.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario